Results 251 to 260 of about 91,065 (316)
Reading and relating with Frieda Fromm‐Reichmann and Joanne Greenberg
Critical Quarterly, EarlyView.
Joshua Pugh
wiley +1 more source
Background Individual differences in the structure and function of the frontostriatal reward network have been related to depression. However, there is a strong need for prospective, longitudinal studies aiming to understand the role of frontostriatal networks in depression in a developmental context.
Marjolein E.A. Barendse +3 more
wiley +1 more source
Background Credible long‐term outcomes from randomized trials evaluating the effectiveness and cost‐effectiveness of preventive programs for mental health problems are needed. We compared long‐term effects of the Mind My Mind (MMM) transdiagnostic cognitive behavioral therapy (CBT) program to management as usual (MAU). Methods The study was a pragmatic,
Ditte Vassard +14 more
wiley +1 more source
Background Studies on the association between victimisation in childhood and adolescence and psychiatric disorders increasingly acknowledge that these associations might be partly confounded by unmeasured familial factors. However, previous quasi‐experimental evidence is largely based on retrospective self‐reported data with potential response biases ...
Joonas Pitkänen +7 more
wiley +1 more source
Background Parental incarceration (PI) is associated with mental and behavioral problems in offspring, but causality remains unclear. We conducted a quasi‐experimental within‐individual study on the associations of PI with offspring psychiatric disorders, suicidal behavior, risk‐taking, and substance misuse events, aiming to test the effect of PI on ...
Aurora Järvinen +8 more
wiley +1 more source
Abstract To evaluate the feasibility and effectiveness of a novel group cognitive remediation (Memory Boost) designed to improve memory in an adult mixed mood and anxiety disorder population. A secondary aim was to explore the relationship between mood symptoms and performance on subjective and objective memory measures.
Catherine Bosyj +4 more
wiley +1 more source
ABSTRACT Aim The aim of this Phase I/II open‐label study was to assess the safety and efficacy of NTI164, a novel full‐spectrum medicinal cannabis plant extract 0.08% Δ‐9‐tetrahydrocannabinol (THC), in Rett syndrome (RTT). Methods Eleven female participants (5–16 years) with a pathogenic variant in the MECP2 gene were recruited to this study, receiving
B. A. Keating +7 more
wiley +1 more source
Novel psychoactive substances - the growing threat
openaire +1 more source

